Emerging Role of Enhancer RNAs as Potential Diagnostic and Prognostic Biomarkers in Cancer

1Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Enhancers are distal cis-acting elements that are commonly recognized to regulate gene expression via cooperation with promoters. Along with regulating gene expression, enhancers can be transcribed and generate a class of non-coding RNAs called enhancer RNAs (eRNAs). The current discovery of abundant tissue-specific transcription of enhancers in various diseases such as cancers raises questions about the potential role of eRNAs in disease diagnosis and therapy. This review aimed to demonstrate the current understanding of eRNAs in cancer research with a focus on the potential roles of eRNAs as prognostic and diagnostic biomarkers in cancers.

Cite

CITATION STYLE

APA

Panahi-Moghadam, S., Hassani, S., Farivar, S., & Vakhshiteh, F. (2022, October 1). Emerging Role of Enhancer RNAs as Potential Diagnostic and Prognostic Biomarkers in Cancer. Non-Coding RNA. MDPI. https://doi.org/10.3390/ncrna8050066

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free